Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the appointment of Michael Tomsicek as Senior Vice President and Chief Financial Officer (CFO). Mr. Tomsicek, who has served as Senior Vice President and Deputy CFO since July 2012, succeeds David McGirr. After more than a decade of leadership at Cubist, Mr. McGirr will serve as Senior Advisor to the Chief Executive Officer (CEO), and retire in 2014.
As CFO, Mr. Tomsicek will oversee Cubist's financial planning and analysis, technical accounting, controllership, treasury, tax, commercial financial services, strategic sourcing activities, investor relations, and facilities functions. Mr. Tomsicek joined Cubist in 2010 as Vice President of Corporate Finance. Prior to Cubist, he spent eight years at General Electric Healthcare, initially as Finance Manager of its global operations, and then as CFO of its diagnostic ultrasound business and CFO of its global ultrasound product group. Previously, Mr. Tomsicek served in a variety of financial and operational roles at Motorola.About Cubist Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s web site at www.cubist.com.